Westwood Holdings Group Inc. Has $18.67 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Westwood Holdings Group Inc. raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 477.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 184,012 shares of the medical device company’s stock after acquiring an additional 152,137 shares during the quarter. Westwood Holdings Group Inc. owned about 0.09% of Cooper Companies worth $18,670,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Benjamin F. Edwards & Company Inc. grew its holdings in Cooper Companies by 248.6% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after purchasing an additional 174 shares during the last quarter. Covestor Ltd boosted its holdings in shares of Cooper Companies by 305.9% during the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after buying an additional 208 shares during the period. Global Retirement Partners LLC grew its stake in Cooper Companies by 358.6% in the 1st quarter. Global Retirement Partners LLC now owns 321 shares of the medical device company’s stock valued at $33,000 after buying an additional 251 shares during the last quarter. Blue Trust Inc. raised its holdings in Cooper Companies by 54.8% in the 4th quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after acquiring an additional 34 shares during the period. Finally, Clearstead Trust LLC acquired a new position in Cooper Companies during the 1st quarter worth $36,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Down 1.0 %

Shares of COO traded down $0.93 during trading hours on Friday, hitting $93.27. 880,304 shares of the stock traded hands, compared to its average volume of 1,253,850. The business has a fifty day moving average of $91.03 and a 200-day moving average of $94.21. The firm has a market capitalization of $18.57 billion, a PE ratio of 54.78, a price-to-earnings-growth ratio of 2.34 and a beta of 0.98. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $104.07. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The business had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. During the same period in the previous year, the firm posted $0.77 earnings per share. Cooper Companies’s revenue for the quarter was up 7.4% compared to the same quarter last year. Analysts expect that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Analyst Ratings Changes

COO has been the subject of several research analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, May 31st. Robert W. Baird upped their price objective on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Piper Sandler reissued an “overweight” rating and set a $115.00 target price on shares of Cooper Companies in a research report on Wednesday, July 3rd. Finally, Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $111.78.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.